Sales Growth YoY (Last 12 Months): Standard BioTools Corp (LAB)

Graphic logo of Standard BioTools Corp (LAB)

Standard BioTools Inc. (LAB) management is finalizing the consolidation of resources in an effort to stabilize current performance metrics. Production relies on external electronics suppliers while maintaining precision assembly in-house. The workforce brings together leading experts in mass cytometry. Year-over-year product sales dynamics for the TTM reflect a market trend where -33.90 is recorded as a baseline value, confirming the growth potential of high-tech laboratories.

Standard BioTools (LAB) - Sales Growth YoY (TTM) from 02/11/2024 to 11/15/2026

Fluidigm (LAB) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price Standard BioTools Corp|LAB - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Standard BioTools Inc.|LAB - Enterprise Value
- balance sheet net asset value indicators:
Equity per Share Standard BioTools|LAB - Book Capitalization|Market Capitalization to Book Value Ratio fluidigm.com|LAB - Aggregate Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Standard BioTools Inc.|LAB - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Fluidigm|LAB - Company Total Debt|Debt to Net Assets Ratio Standard BioTools Inc.|LAB - Company Long-Term Debts|Company Short-Term Debt Standard BioTools|Interim Coverage Ratio fluidigm.com
- earnings and valuation multiples indicators:
LAB - Company Net Income|Expected Net Profit Standard BioTools Inc.|LAB - Price to Earnings Ratio|Market Cap to Future Earnings Ratio fluidigm.com|LAB - Price/Earnings to Growth Ratio|Company Value to EBITDA Standard BioTools Inc|LAB - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Standard BioTools|LAB - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months fluidigm.com|LAB - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Standard BioTools Inc.
- sales revenue and business income indicators:
LAB - Company Sales|Company Future Revenue Fluidigm|LAB - P/S Multiple|Market Cap to Expected Sales Ratio Standard BioTools Inc|LAB - Sales Growth YoY (Last Twelve Months)
Fundamental company valuation:Fluidigm
Brand item of Standard BioTools Inc

This indicator measures the revenue growth rate over a rolling year, allowing investors to assess the resilience of consumer demand and the business's fundamental margin of safety. Analyzing the revenue trend over four quarters year-over-year is critical for Standard BioTools Inc. (LAB), as it helps identify the impact of US trade restrictions and Asian supply chain disruptions on global equipment sales.

Who Standard BioTools Inc. competes with

Agilent Corp (A) - Trailing Twelve Months Revenue Growth|DGX - Sales Growth YoY (Last Twelve Months)|ILMN: Sales Growth YoY (Last Twelve Months)|EXAS: Sales Growth YoY (TTM)|RVTY (Revvity) - Sales Growth YoY (Last Twelve Months)|BIO (Bio-Rad Laboratories, Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Anbio Biotechnology NNNN|Revenue Growth YoY (Last 12 Months) SHC (Sotera Health Company)|Sales Growth YoY (Last Twelve Months) QDEL (quidel.com)|Sales Growth YoY (TTM) OPK (opko.com)|Revenue Dynamics YoY (Last Twelve Months) CDNA|MRVI: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) FLGT (Fulgent Corp)|Cytek Biosciences Inc (CTKB) - Sales Growth YoY (Last Twelve Months)|OSUR: Revenue Change YoY (Last 12 Months)|Revenue Growth YoY (Last 12 Months) XGN|MDXH: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Lucid Diagnostics Inc. (LUCD)|Sales Growth YoY (Last Twelve Months) PRE (Prenetics Global Limited)|Sales Growth YoY (TTM) IMDX (Insight Molecular Diagnostics Inc)|Revenue Change YoY (Last 12 Months) TRIB (Trinity Biotech Corp)|PRPH - Sales Growth YoY (Last Twelve Months)|Ainos (AIMD) - Revenue Growth YoY (Last 12 Months)|CoDx (CODX) - Sales Growth YoY (Last Twelve Months)|HSCS (Heart Test Labs) - Sales Growth YoY (Last Twelve Months)|BMRA (Biomerica, Inc.) - Sales Growth YoY (TTM)|CDIO (Cardio Diagnostics) - Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Onconetix Corp (ONCO)|VRAX (Virax Biolabs Group Limited) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BJDX (Bluejay Diagnostics Corp)|Aspira Women's Health - Sales Growth YoY (Last Twelve Months)|AXDX - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Centogene NV (CNTG)|ENZ (Enzo Biochem) - Revenue Growth YoY (Last 12 Months)|fresh2.co (FRES) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Genetic Technologies Limited|Trailing Twelve Months Revenue Growth 23andMe Inc. ME|Sales Growth YoY (Last Twelve Months) Psychemedics (PMD)